Feasibility of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

Trial Profile

Feasibility of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs LUM 015 (Primary)
  • Indications Breast cancer
  • Focus Diagnostic use; First in man
  • Sponsors Lumicell
  • Most Recent Events

    • 03 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2017.
    • 22 Aug 2017 Planned End Date changed from 1 Jun 2016 to 1 Sep 2017.
    • 22 Aug 2017 Planned primary completion date changed from 1 May 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top